Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

PRHSX vs. HIAHX: which is better?

Bottom line

PRHSX vs HIAHX: the short answer

PRHSX (T. Rowe Price Health Sciences Fund, Inc.) and HIAHX (Hartford Healthcare Hls Fund) share a meaningful slice of their top holdings — about 65% by weight.

But PRHSX is far broader, holding 279 positions to 79 for HIAHX, so beyond the top names it adds exposure HIAHX doesn't have.

PRHSX is cheaper at 0.83% vs 0.94% — a difference of $11 a year per $10,000 invested.

Over five years, PRHSX returned +4.2% a year vs +3.5% for HIAHX.

Updated Nov 19, 2026

PRHSX vs HIAHX side by side

PRHSXHIAHX
TypeMutual fundMutual fund
Fund familyT. Rowe PriceHartford
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.83%0.94%
Annual cost per $10k$83$94
10-yr cost on $10k (prospectus)$1,025$1,155
Max front load——
12b-1 fee—0%
1-yr return+17.7%+16.1%
5-yr return (annualized)+4.2%+3.5%
10-yr return (annualized)+9.1%+7.9%
Best quarter+23.5%+21.0%
Worst quarter−15.8%−15.6%
Net assets (fund)$11.9B$112.4M
Number of holdings27979
Portfolio turnover62%5%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearPRHSXHIAHXDifference
2025+17.7%+16.1%+1.6%
2024+1.8%+0.4%+1.4%
2023+3.1%+4.1%−1.0%
2022−12.2%−11.2%−0.9%
2021+13.3%+10.0%+3.3%
2020+30.1%+23.1%+7.0%
2019+29.1%+34.0%−4.8%
2018+1.2%−2.7%+3.9%
2017+28.0%+22.3%+5.7%
2016−10.4%−8.4%−2.0%

Source: Fund prospectus bar charts

Holdings overlap

14 of PRHSX's top 25 holdings also appear in HIAHX's top 25.

Shared top holdings
HoldingPRHSXHIAHX
Eli Lilly & Co14.28%12.47%
Johnson & Johnson6.63%6.63%
Unitedhealth Group Inc5.99%4.72%
Abbvie Inc5.10%3.43%
Merck & Co. Inc.4.01%6.60%
Thermo Fisher Scientific Inc2.52%1.64%
Vertex Pharmaceuticals Inc2.28%2.69%
Abbott Laboratories1.89%2.10%
Intuitive Surgical Inc1.87%2.99%
Stryker Corp1.78%1.17%
Elevance Health Inc1.53%2.96%
Danaher Corp1.43%2.65%
Cardinal Health Inc1.03%1.81%
Cvs Health Corp0.94%2.93%

Source: SEC Form N-PORT

PRHSX top 10

  1. Eli Lilly & Co — 14.28%
  2. Johnson & Johnson — 6.63%
  3. Unitedhealth Group Inc — 5.99%
  4. Abbvie Inc — 5.10%
  5. Merck & Co. Inc. — 4.01%
  6. Gilead Sciences Inc — 2.82%
  7. Thermo Fisher Scientific Inc — 2.52%
  8. Vertex Pharmaceuticals Inc — 2.28%
  9. Bristol-myers Squibb Co — 2.11%
  10. Abbott Laboratories — 1.89%

HIAHX top 10

  1. Eli Lilly & Co — 12.47%
  2. Johnson & Johnson — 6.63%
  3. Merck & Co Inc — 6.60%
  4. UnitedHealth Group Inc — 4.72%
  5. AbbVie Inc — 3.43%
  6. Intuitive Surgical Inc — 2.99%
  7. Elevance Health Inc — 2.96%
  8. CVS Health Corp — 2.93%
  9. Vertex Pharmaceuticals Inc — 2.69%
  10. Danaher Corp — 2.65%

FAQ

What is the difference between PRHSX and HIAHX?
PRHSX (T. Rowe Price Health Sciences Fund, Inc.) and HIAHX (Hartford Healthcare Hls Fund) share a meaningful slice of their top holdings — about 65% by weight. But PRHSX is far broader, holding 279 positions to 79 for HIAHX, so beyond the top names it adds exposure HIAHX doesn't have.
Which is cheaper, PRHSX or HIAHX?
PRHSX has the lower expense ratio (0.83%).
Should I own both PRHSX and HIAHX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.